Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Niagen Bioscience (NAGE) Asset Utilization Ratio: 2011-2025

Historic Asset Utilization Ratio for Niagen Bioscience (NAGE) over the last 7 years, with Sep 2025 value amounting to 1.32.

  • Niagen Bioscience's Asset Utilization Ratio fell 20.70% to 1.32 in Q3 2025 from the same period last year, while for Sep 2025 it was 1.32, marking a year-over-year decrease of 20.70%. This contributed to the annual value of 1.62 for FY2024, which is 5.43% up from last year.
  • Per Niagen Bioscience's latest filing, its Asset Utilization Ratio stood at 1.32 for Q3 2025, which was down 2.27% from 1.35 recorded in Q2 2025.
  • Niagen Bioscience's Asset Utilization Ratio's 5-year high stood at 1.66 during Q3 2024, with a 5-year trough of 1.03 in Q3 2021.
  • Its 3-year average for Asset Utilization Ratio is 1.50, with a median of 1.53 in 2024.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first skyrocketed by 44.59% in 2022, then fell by 20.70% in 2025.
  • Quarterly analysis of 5 years shows Niagen Bioscience's Asset Utilization Ratio stood at 1.14 in 2021, then climbed by 26.71% to 1.45 in 2022, then increased by 6.66% to 1.54 in 2023, then grew by 3.56% to 1.60 in 2024, then decreased by 20.70% to 1.32 in 2025.
  • Its Asset Utilization Ratio was 1.32 in Q3 2025, compared to 1.35 in Q2 2025 and 1.44 in Q1 2025.